Literature DB >> 21532956

Presentations of primary hypersomnia in Chinese children.

Fang Han1, Ling Lin, Jing Li, Adi Aran, Song X Dong, Pei An, Long Zhao, Ming Li, Qian Y Li, Han Yan, Jie S Wang, Hui Y Gao, Mei Li, Zhan C Gao, Kingman P Strohl, Emmanuel Mignot.   

Abstract

OBJECTIVE: To retrospectively describe childhood presentations of primary hypersomnia with an emphasis on narcolepsy-cataplexy in a Chinese population.
METHODS: A total of 417 children (< 18 years old) successively presenting with complaints of hypersomnia without anatomic cause or sleep apnea risk were evaluated using the Stanford Sleep Inventory, human leukocyte antigen (HLA) DQB1*0602 typing, and MSLT recordings. CSF hypocretin-1 was measured in 47 cases to document hypocretin deficiency. A subgroup ("narcolepsy/hypocretin deficiency") with likely hypocretin deficiency (low hypocretin-1 or HLA positive with clear-cut cataplexy) was further examined for presentations prior to, around, or after puberty.
RESULTS: Narcolepsy with (n = 361) or without (n = 17) cataplexy presented at an earlier age and with increased male predominance when compared to idiopathic hypersomnia (n = 39, P < 0.01). Nearly 70% of those with narcolepsy/hypocretin deficiency (n = 271) had disease onset before age 10 y, and 15% had onset before age 6, an unusually young age distribution. Onset was prior to puberty in 78% of cases. Clinical features were similar in presentations across puberty groups except for sleep paralysis, which increased in frequency with age/puberty. Mean sleep latency (MSL) decreased and the number of sleep onset REM periods (SOREMPs) increased with age/puberty, but MSLT diagnosis criteria (MSL ≤ 8 min, ≥ 2 SOREMPs) were similarly positive across groups. Familial clustering was present in only 1.7% of probands.
CONCLUSION: In children presenting with a complaint of primary hypersomnia to a sleep clinic in China, 86% (361/417) meet criteria for narcolepsy with cataplexy. Puberty did not affect positivity on the MSLT as a diagnostic feature. Sleep paralysis was the only symptom that increased with increasing age. In addition, narcolepsy with cataplexy in our clinic population appeared to begin at a younger age than usually reported in other studies.

Entities:  

Keywords:  HLADQB1*0602; MSLT; Narcolepsy; childhood; hypocretin

Mesh:

Substances:

Year:  2011        PMID: 21532956      PMCID: PMC3079942          DOI: 10.1093/sleep/34.5.627

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  30 in total

1.  Childhood narcolepsy in North China.

Authors:  F Han; E Chen; H Wei; X Dong; Q He; D Ding; K P Strohl
Journal:  Sleep       Date:  2001-05-01       Impact factor: 5.849

2.  DQB1*0301 and DQB1*0601 modulate narcolepsy susceptibility in Koreans.

Authors:  Seung-Chul Hong; Ling Lin; Betty Lo; Jong-Hyun Jeong; Yoon-Kyung Shin; Su-Yeon Kim; Yongsil Kweon; Jing Zhang; Mali Einen; Anajane Smith; John Hansen; F Carl Grumet; Emmanuel Mignot
Journal:  Hum Immunol       Date:  2006-10-30       Impact factor: 2.850

3.  Clinical, polysomnographic and laboratory characteristics of narcolepsy-cataplexy in a sample of children and adolescents.

Authors:  Rosa Peraita-Adrados; Juan J García-Peñas; Luz Ruiz-Falcó; Luis Gutiérrez-Solana; Pilar López-Esteban; José L Vicario; Silvia Miano; Manuel Aparicio-Meix; María-José Martinez-Sopena
Journal:  Sleep Med       Date:  2010-11-02       Impact factor: 3.492

4.  Age at onset of narcolepsy in two large populations of patients in France and Quebec.

Authors:  Y Dauvilliers; J Montplaisir; N Molinari; B Carlander; B Ondze; A Besset; M Billiard
Journal:  Neurology       Date:  2001-12-11       Impact factor: 9.910

5.  Concomitant loss of dynorphin, NARP, and orexin in narcolepsy.

Authors:  A Crocker; R A España; M Papadopoulou; C B Saper; J Faraco; T Sakurai; M Honda; E Mignot; T E Scammell
Journal:  Neurology       Date:  2005-09-14       Impact factor: 9.910

6.  A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains.

Authors:  C Peyron; J Faraco; W Rogers; B Ripley; S Overeem; Y Charnay; S Nevsimalova; M Aldrich; D Reynolds; R Albin; R Li; M Hungs; M Pedrazzoli; M Padigaru; M Kucherlapati; J Fan; R Maki; G J Lammers; C Bouras; R Kucherlapati; S Nishino; E Mignot
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

7.  A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness.

Authors:  Seung-Chul Hong; Ling Lin; Jong-Hyun Jeong; Yoon-Kyung Shin; Jin-Hee Han; Ji-Hyun Lee; Sung-Pil Lee; Jing Zhang; Mali Einen; Emmanuel Mignot
Journal:  Sleep       Date:  2006-11       Impact factor: 5.849

8.  Narcolepsy in Southern Chinese patients: clinical characteristics, HLA typing and seasonality of birth.

Authors:  Y K Wing; L Chen; S Y Y Fong; M H L Ng; C K W Ho; S H Cheng; N L S Tang; A M Li
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-04-03       Impact factor: 10.154

9.  Cataplexy features in childhood narcolepsy.

Authors:  Leonardo Serra; Pasquale Montagna; Emmanuel Mignot; Elio Lugaresi; Giuseppe Plazzi
Journal:  Mov Disord       Date:  2008-04-30       Impact factor: 10.338

10.  Reduced number of hypocretin neurons in human narcolepsy.

Authors:  T C Thannickal; R Y Moore; R Nienhuis; L Ramanathan; S Gulyani; M Aldrich; M Cornford; J M Siegel
Journal:  Neuron       Date:  2000-09       Impact factor: 17.173

View more
  9 in total

Review 1.  The diagnosis and treatment of pediatric narcolepsy.

Authors:  Sona Nevsimalova
Journal:  Curr Neurol Neurosci Rep       Date:  2014-08       Impact factor: 5.081

2.  Narcolepsy in the pediatric population.

Authors:  Erick N Viorritto; Suraiya A Kureshi; Judith A Owens
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

3.  Tolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: a retrospective study.

Authors:  Michel Lecendreux; Francesca Poli; Delphine Oudiette; Fatima Benazzouz; Claire E H M Donjacour; Christian Franceschini; Elena Finotti; Fabio Pizza; Oliviero Bruni; Giuseppe Plazzi
Journal:  Sleep       Date:  2012-05-01       Impact factor: 5.849

4.  TCRA, P2RY11, and CPT1B/CHKB associations in Chinese narcolepsy.

Authors:  Fang Han; Ling Lin; Jing Li; Adi Aran; Song X Dong; Pei An; Long Zhao; Qian Y Li; Han Yan; Jie S Wang; Hui Y Gao; Mei Li; Zhan C Gao; Kingman P Strohl; Emmanuel Mignot
Journal:  Sleep Med       Date:  2011-12-15       Impact factor: 3.492

5.  Cerebrospinal Fluid Orexin A Levels and Autonomic Function in Kleine-Levin Syndrome.

Authors:  Jing Yu Wang; Fang Han; Song X Dong; Jing Li; Pei An; Xiao Zhe Zhang; Yuan Chang; Long Zhao; Xue Li Zhang; Ya Nan Liu; Han Yan; Qing Hua Li; Yan Hu; Chang Jun Lv; Zhan Cheng Gao; Kingman P Strohl
Journal:  Sleep       Date:  2016-04-01       Impact factor: 5.849

6.  HLA-DQB1*06:02 allele frequency and clinic-polysomnographic features in Saudi Arabian patients with narcolepsy.

Authors:  Saad M Al Shareef; Eiman AlAnbay; Mujahed A AlKhathlan; Zahid Shakoor; Mustafa Alnasser; Khalid D Hamam; Adel S Alharbi; Aljohara S Almeneessier; Ahmed S BaHammam
Journal:  Sleep Breath       Date:  2018-09-05       Impact factor: 2.816

Review 7.  History of narcolepsy at Stanford University.

Authors:  Emmanuel J M Mignot
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

8.  Genome wide analysis of narcolepsy in China implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic.

Authors:  Fang Han; Juliette Faraco; Xiao Song Dong; Hanna M Ollila; Ling Lin; Jing Li; Pei An; Shan Wang; Ke Wei Jiang; Zhan Cheng Gao; Long Zhao; Han Yan; Ya Nan Liu; Qing Hua Li; Xiao Zhe Zhang; Yan Hu; Jing Yu Wang; Yun Hui Lu; Chang Jun Lu; Wei Zhou; Joachim Hallmayer; Yu Shu Huang; Kingman P Strohl; Thomas Pollmächer; Emmanuel Mignot
Journal:  PLoS Genet       Date:  2013-10-31       Impact factor: 5.917

9.  Evaluation of psychometric properties of patient-reported outcome measures frequently used in narcolepsy randomized controlled trials: a systematic review.

Authors:  Aaron Schokman; Yu Sun Bin; Diana Naehrig; Janet M Y Cheung; Kristina Kairaitis; Nick Glozier
Journal:  Sleep       Date:  2022-10-10       Impact factor: 6.313

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.